Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.25% | -39.46% | -67.79% | -7.01% | -63.33% |
| Total Depreciation and Amortization | 71.55% | 127.78% | 58.25% | 48.43% | 12.73% |
| Total Amortization of Deferred Charges | -14.50% | -12.57% | -5.30% | -4.12% | -0.95% |
| Total Other Non-Cash Items | -103.71% | 1,666.19% | 158.35% | -24.41% | 140.91% |
| Change in Net Operating Assets | 2.84% | -233.86% | 188.34% | -75.89% | -19.88% |
| Cash from Operations | 15.01% | -26.34% | -21.47% | -67.19% | -42.41% |
| Capital Expenditure | 65.44% | -144.96% | 34.45% | 48.64% | -115.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 197.30% | 193.08% | 24.00% | -- | -69.84% |
| Cash from Investing | 230.20% | 195.55% | 24.04% | 3,458.91% | -72.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.17% | -13.12% | -13.53% | -318.14% | -13.69% |
| Issuance of Common Stock | 2.05% | 152.29% | -91.41% | 10.08% | 633.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.78% | -78.75% | -91.59% | 9.77% | 859.56% |
| Foreign Exchange rate Adjustments | -161.79% | 100.47% | -153.07% | 246.08% | 193.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.27% | 87.74% | -20.91% | 35.33% | -233.90% |